These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 3481847

  • 1. [Early daunorubicin cardiotoxicity and fatal outcome in a child with acute myeloblastic leukemia (M2)].
    Rizzari C, Santamaria M, Galli MA, Jankovic M, Uderzo C.
    Pediatr Med Chir; 1987; 9(6):749-50. PubMed ID: 3481847
    [Abstract] [Full Text] [Related]

  • 2. [Studies on the cardiotoxicity of daunomycin in patients with acute leukemia].
    Marni E, Marchi A, Laini C, Zanol MG, Martini A, Livieri C, Genova R.
    Minerva Pediatr; 1978 Feb 28; 30(4):333-8. PubMed ID: 273716
    [No Abstract] [Full Text] [Related]

  • 3. Early onset of daunomycin cardiotoxicity in a case of acute myelogeneous leukemia associated with Sweet's syndrome.
    Imamura N, Miura K, Kuramoto A.
    Hiroshima J Med Sci; 1985 Jun 28; 34(2):253-6. PubMed ID: 3861598
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Sudden death in leukemic patients treated with doxorubicin].
    Lacasse Y, Bolduc P.
    Can J Cardiol; 1992 Jun 28; 8(1):53-6. PubMed ID: 1617512
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of dexrazoxane as a cardioprotective agent in patients receiving mitoxantrone- and daunorubicin-based chemotherapy.
    Lemez P, Maresová J.
    Semin Oncol; 1998 Aug 28; 25(4 Suppl 10):61-5. PubMed ID: 9768826
    [Abstract] [Full Text] [Related]

  • 7. Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I-II study.
    Fassas A, Buffels R, Anagnostopoulos A, Gacos E, Vadikolia C, Haloudis P, Kaloyannidis P.
    Br J Haematol; 2002 Feb 28; 116(2):308-15. PubMed ID: 11841431
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Heart transplant in a childhood leukemia survivor: a case report.
    Urbanova D, Bubanska E, Hrebik M, Mladosievicova B.
    Exp Clin Transplant; 2010 Mar 28; 8(1):79-81. PubMed ID: 20199376
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Cardiac insufficiency caused by the use of daunorubicin. Clinical and developmental study of 4 recent cases].
    Bauters F, Plouvier B, Breviere G, Goudemand M.
    Sem Hop; 1975 Jun 14; 51(28):1949-57. PubMed ID: 180611
    [Abstract] [Full Text] [Related]

  • 19. Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia.
    Thomas X, Le QH, Fiere D.
    Ann Hematol; 2002 Sep 14; 81(9):504-7. PubMed ID: 12373350
    [Abstract] [Full Text] [Related]

  • 20. [Daunomycin and atrial fibrillation].
    Fuster Siebert M, Fernández Iglesias A, Couselo Sánchez JM, Gallego García D, Iglesias Diz JL, Alvez González F.
    An Esp Pediatr; 1983 Nov 14; 19(5):415-6. PubMed ID: 6581751
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.